Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
H Jacobsen, I Sitaras, M Katzmarzyk, V Cobos Jiménez… - npj Vaccines, 2023 - nature.com
Mass COVID-19 vaccination and continued introduction of new SARS-CoV-2 variants
increased prevalence of hybrid immunity at various stages of waning protection. We …
increased prevalence of hybrid immunity at various stages of waning protection. We …
[HTML][HTML] Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly
IATM Ferreira, CYC Lee, WS Foster, A Abdullahi… - Cell Reports, 2023 - cell.com
Suboptimal responses to a primary vaccination course have been reported in the elderly, but
there is little information regarding the impact of age on responses to booster third doses …
there is little information regarding the impact of age on responses to booster third doses …
Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults
T Samandari, JB Ongalo, KD McCarthy… - The Journal of …, 2023 - Am Soc Clin Investig
Background SARS-CoV-2 infection in Africa has been characterized by a less severe
disease profile than what has been observed elsewhere, but the profile of SARS-CoV-2 …
disease profile than what has been observed elsewhere, but the profile of SARS-CoV-2 …
Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
J Serwanga, V Ankunda, J Sembera, L Kato… - Frontiers in …, 2023 - frontiersin.org
Introduction Understanding how spike (S)-, nucleoprotein (N)-, and RBD-directed antibody
responses evolved in mild and asymptomatic COVID-19 in Africa and their interactions with …
responses evolved in mild and asymptomatic COVID-19 in Africa and their interactions with …
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine …
J Serwanga, C Baine, S Mugaba, V Ankunda… - Frontiers in …, 2023 - frontiersin.org
Introduction The duration and timing of immunity conferred by COVID-19 vaccination in sub-
Saharan Africa are crucial for guiding pandemic policy interventions, but systematic data for …
Saharan Africa are crucial for guiding pandemic policy interventions, but systematic data for …
Waning of post-vaccination neutralizing antibody responses against SARS-CoV-2, a systematic literature review and meta-analysis
H Jacobsen, I Sitaras, M Katzmarzyk, V Cobos Jimenez… - MedRxiv, 2023 - medrxiv.org
Background Mass COVID-19 vaccination and the continuous introduction of new viral
variants of SARS-CoV-2, especially of Omicron subvariants, has resulted in an increase in …
variants of SARS-CoV-2, especially of Omicron subvariants, has resulted in an increase in …
The subdued post-boost spike-directed secondary igG antibody response in Ugandan recipients of the pfizer-bioNTech BNT162b2 vaccine has implications for local …
V Ankunda, JS Katende, GK Oluka, J Sembera… - Frontiers in …, 2024 - frontiersin.org
Introduction This study aimed to delineate longitudinal antibody responses to the Pfizer-
BioNTech BNT162b2 COVID-19 vaccine within the Ugandan subset of the Sub-Saharan …
BioNTech BNT162b2 COVID-19 vaccine within the Ugandan subset of the Sub-Saharan …
Trends in SARS-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia: A repeated cross-sectional survey, 2021–2022
E Heilmann, T Tembo, S Fwoloshi… - PLOS Global Public …, 2024 - journals.plos.org
SARS-CoV-2 serosurveys help estimate the extent of transmission and guide the allocation
of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women …
of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women …
The single-dose Janssen Ad26. COV2. S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort
J Serwanga, L Kato, GK Oluka, V Ankunda… - Frontiers in …, 2024 - frontiersin.org
Introduction The study investigation examined the immune response to the Janssen Ad26.
COV2. S COVID-19 vaccine within a Ugandan cohort, specifically targeting antibodies …
COV2. S COVID-19 vaccine within a Ugandan cohort, specifically targeting antibodies …
[HTML][HTML] Performance of SARS COV-2 IgG anti-N as an independent marker of exposure to SARS COV-2 in an unvaccinated west african population
Determination of previous SARS-COV-2 infection is hampered by the absence of a
standardized test. The marker used to assess previous exposure is IgG antibody to the …
standardized test. The marker used to assess previous exposure is IgG antibody to the …